Strengthening Program for Pharmaceutical Startup Ecosystem
Funds Japanese pharmaceutical startups from preclinical to phase two growth with venture-collaborative backing.
The Strengthening Program for Pharmaceutical Startup Ecosystem is an AMED subsidy program that supports pharmaceutical startups carrying out practical drug development — covering non-clinical studies, Phase 1 trials, Phase 2 trials, and exploratory clinical trials — where a registered venture capital firm invests more than one-third of the total expenses covered by the subsidy. The program was est…
Vaccines, therapeutics, and drug discovery technologies across all disease areas (expanded from infectious disease only in October 2022).
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
BudgetGrant Financials and Co-Funding Evidence: Examples for Startup Applications
See examples of grant financials, match funding evidence, co-funding tables, accountant letters, investor commitments, and budget-to-work-plan checks.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
DocumentsProof-of-Concept Data for Grants: Evidence Examples for Deeptech Applications
See how to present proof-of-concept data in grant applications, with examples for evidence registers, test logs, pilot data, and prior project proof.
Similar grants
Browse the directory →
Japanese SBIR Promotion Program
🇯🇵METI · Japan
Funds Japanese small and medium-sized businesses with staged innovation support from concept to advanced development.
JETRO Startup Acceleration
🇯🇵JETRO · Japan
Offers continual acceleration pathways for Japanese startups entering new global markets through mentorship and market entry support.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33)
NIH · United States
Funds early-stage testing of a novel-mechanism drug or a device for mental disorders, designed to show a dose-dependent effect on the target.
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
NIH · United States
Funds a feasibility phase then a testing phase for a novel-mechanism drug or a device for mental disorders, with milestones between them.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.